Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
76.43
-3.15 (-3.96%)
At close: May 1, 2024, 4:00 PM
78.25
+1.82 (2.38%)
After-hours: May 1, 2024, 7:59 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 27 employees on December 31, 2023. The number of employees increased by 6 or 28.57% compared to the previous year.
Employees
27
Change (1Y)
6
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,471,111
Market Cap
8.43B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27 | 6 | 28.57% |
Dec 31, 2022 | 21 | 3 | 16.67% |
Dec 31, 2021 | 18 | -2 | -10.00% |
Dec 31, 2020 | 20 | 3 | 17.65% |
Dec 31, 2019 | 17 | -1 | -5.56% |
Dec 31, 2018 | 18 | 4 | 28.57% |
Dec 31, 2017 | 14 | 2 | 16.67% |
Dec 31, 2016 | 12 | 2 | 20.00% |
Dec 31, 2015 | 10 | 6 | 150.00% |
Jun 15, 2014 | 4 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Chemed | 15,087 |
AptarGroup | 13,800 |
Qiagen | 5,967 |
Stevanato Group | 5,634 |
Legend Biotech | 1,826 |
Repligen | 1,783 |
VKTX News
- 7 days ago - Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 10 days ago - Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX - Invezz
- 14 days ago - Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 - PRNewsWire
- 15 days ago - Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. - Market Watch
- 21 days ago - This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? - Market Watch
- 26 days ago - Viking Files Registration Statement with SEC for Proposed Initial Public Offering - PRNewsWire
- 4 weeks ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz
- 4 weeks ago - Healthcare stocks fade as obesity-drug optimism fades - Market Watch